$Canaan (CAN.US)$ Chinese concept stocks collectively took a dive, with alibaba plummeting by two-thirds. The US used a pretext of auditing and clamored for the delisting of Chinese concept stocks. On the Chinese side, the actions of futu and tiger in attracting customers in China were defined as driving without a license. It seems to be quite coordinated. It appears that the policies of both countries do not want Chinese concept stocks to continue thriving in the US. They can only delist gradually through privatization and turn to Hong Kong, right? If they collectively fall below one US dollar and are forcibly delisted, that would be very embarrassing. The question is, can Hong Kong handle the re-listing of trillions of US dollars worth of Chinese concept stocks? It would be strange if the Hang Seng Index doesn't fall. Clearly, there is an overabundance of stocks compared to demand.
Translated
3
$Shenzhen Zqgame (300052.SZ)$ Recently, stocks related to the concept of metaverse have remained hot, with several individual stocks experiencing astonishing short-term gains, attracting high attention from regulatory authorities. Following the attention letters received by companies such as Col Group Co.,Ltd., Hubei Century Network Technology Inc., and Inmyshow Digital Technology from the exchange, the newly-rising star in the metaverse concept, Easy Show Display, which had consecutively hit the limit up for 4 days, also received a letter of concern from the Shenzhen Stock Exchange yesterday evening. Regarding the recent increase in the company's stock price, the letter directly inquired: Are you riding the metaverse trend?
Despite the continuous attention from regulatory authorities on the metaverse concept, it has failed to extinguish investors' speculation enthusiasm. Overnight, Roblox, the first metaverse stock listed on the Nasdaq in the USA, surged over 40%, hitting a new high since its IPO. This once again injected momentum into the A-share metaverse speculation. Easy Show Display, after opening slightly lower, quickly adjusted upwards once again and closed at the limit up by midday.
The metaverse concept index, which just recently adjusted, soared with a gap up opening today, surging over 4% against the market trend with large trading volume, setting another historical high. Col Group Co.,Ltd., Wuhan P&S Information Technology surged by 20%, Beijing Philisense Technology, and Wuhu Token Sciences hit the limit up or rose by over 10%.
The speculation on the metaverse concept not only remains unaffected by regulations but also shows signs of diffusion. Today, in response to investor inquiries about whether the company holds shares in Uki, a social metaverse similar to Facebook, Guizhou Yongji Printing replied on the Interactive Platform that the company's investment fund Arrow Xie Yi Yongji holds 6.8% equity of Shanghai Niuka Information Technology Co., Ltd. The company will fulfill disclosure obligations in a timely manner based on future developments and relevant regulations. Guizhou Yongji Printing soared from near flat in the early trading, surging in a straight line within a few minutes.
Hangzhou Anysoft Information Technology announced today to promote cooperation in the VR field, drive VR industry development, signed a "Strategic Cooperation Framework Agreement" on November 9, 2021, with China Mobile (Jiangxi) Virtual Reality Technology Co., Ltd., and Datao Robot Co., Ltd., based on the principles of complementary advantages, mutual benefit, equality, and long-term cooperation. The agreement aims to achieve strategic cooperation in the fields of VR/AR, robot metaverse, artificial intelligence, digital twin, and more. Hangzhou Anysoft Information Technology surged significantly in the early trading and hit the limit up within seconds after opening, with the first minute's trading volume exceeding the total volume of the previous day.
Despite the continuous attention from regulatory authorities on the metaverse concept, it has failed to extinguish investors' speculation enthusiasm. Overnight, Roblox, the first metaverse stock listed on the Nasdaq in the USA, surged over 40%, hitting a new high since its IPO. This once again injected momentum into the A-share metaverse speculation. Easy Show Display, after opening slightly lower, quickly adjusted upwards once again and closed at the limit up by midday.
The metaverse concept index, which just recently adjusted, soared with a gap up opening today, surging over 4% against the market trend with large trading volume, setting another historical high. Col Group Co.,Ltd., Wuhan P&S Information Technology surged by 20%, Beijing Philisense Technology, and Wuhu Token Sciences hit the limit up or rose by over 10%.
The speculation on the metaverse concept not only remains unaffected by regulations but also shows signs of diffusion. Today, in response to investor inquiries about whether the company holds shares in Uki, a social metaverse similar to Facebook, Guizhou Yongji Printing replied on the Interactive Platform that the company's investment fund Arrow Xie Yi Yongji holds 6.8% equity of Shanghai Niuka Information Technology Co., Ltd. The company will fulfill disclosure obligations in a timely manner based on future developments and relevant regulations. Guizhou Yongji Printing soared from near flat in the early trading, surging in a straight line within a few minutes.
Hangzhou Anysoft Information Technology announced today to promote cooperation in the VR field, drive VR industry development, signed a "Strategic Cooperation Framework Agreement" on November 9, 2021, with China Mobile (Jiangxi) Virtual Reality Technology Co., Ltd., and Datao Robot Co., Ltd., based on the principles of complementary advantages, mutual benefit, equality, and long-term cooperation. The agreement aims to achieve strategic cooperation in the fields of VR/AR, robot metaverse, artificial intelligence, digital twin, and more. Hangzhou Anysoft Information Technology surged significantly in the early trading and hit the limit up within seconds after opening, with the first minute's trading volume exceeding the total volume of the previous day.
Translated
3
$Pfizer (PFE.US)$ buy buy buy, going to the moon
16
$Pfizer (PFE.US)$ Pfizer pill for covid is available, 89% risk reduce for death and hospitalization, the share price will double. much better than MRK's 50%. buy buy buy
6
3
$Pfizer (PFE.US)$ Pfizer's special medicine is out, in the future when traveling, just put two boxes of pfizer covid medicine in your pocket, if infected, take it out and eat for five days, recover immediately...
I've been telling you to buy pfizer for a long time, you just don't listen, now it's going to double... Buy buy buy...
I've been telling you to buy pfizer for a long time, you just don't listen, now it's going to double... Buy buy buy...
Translated
5
2
$Pfizer (PFE.US)$ The Moderna vaccine is not competitive enough, and the quality is unstable. Pfizer is seizing the market. Just look at the vaccinations received by the heads of state. All presidents have been vaccinated with the Pfizer vaccine, buy buy
Translated
3
1
$Futu Holdings Ltd (FUTU.US)$ I told you guys to buy days ago at the most trough. you have made tons of money if follow my suggestions, congratulations😄
6
3
$CNOOC (00883.HK)$ CNOOC is severely undervalued, with other oil companies experiencing much higher gains than CNOOC. Additionally, due to the skyrocketing natural gas prices, CNOOC is benefiting and maintaining stable dividends. Buy, buy, buy.
Translated
10
$Pfizer (PFE.US)$ Raises Full-Year 2021 Guidance(4) for Revenues to a Range of $81.0 to $82.0 Billion and Adjusted Diluted EPS(3) to a Range of $4.13 to $4.18, Reflecting 94% and 84% Year-Over-Year Growth at the Midpoints, Respectively
PE ratio is 9%, buy buy buy ..... .....
PE ratio is 9%, buy buy buy ..... .....
3
$Pfizer (PFE.US)$ Pfizer's pill will be approved soon, buy...
The mid-to-late-stage study will test Pfizer's drug, PF-07321332, in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic COVID-19 infection.
In the trial, PF-07321332, designed to block the activity of a key enzyme needed for the coronavirus to multiply, will be administered along with a low dose of ritonavir, an older medication widely used in combination treatments for HIV infection.
The mid-to-late-stage study will test Pfizer's drug, PF-07321332, in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic COVID-19 infection.
In the trial, PF-07321332, designed to block the activity of a key enzyme needed for the coronavirus to multiply, will be administered along with a low dose of ritonavir, an older medication widely used in combination treatments for HIV infection.
6